Objective: Divalproex extended release (ER) tablets have lower bioavailability than conventional divalproex tablets. Objectives were to provide dose-increment justification for conversion of a ...
Divalproex sodium 250mg, 500mg; ext-rel tabs. Increased risk of hepatotoxicity in patients with congenital metabolic disorders, multiple AEDs, severe seizure disorders with mental retardation ...
Divalproex sodium 125mg; coated particles in caps. Increased risk of hepatotoxicity in patients with congenital metabolic disorders, multiple AEDs, severe seizure disorders with mental retardation ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results